Long term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801

被引:15
作者
Black, Dalliah M. [1 ]
Hunt, Kelly K. [1 ]
Mittendorf, Elizabeth A. [1 ]
机构
[1] Univ Texas Houston, MD Anderson Canc Ctr, Dept Surg Oncol, Unit 1484, 1400 Pressler Blvd, Houston, TX 77030 USA
关键词
Breast conserving therapy (BCT); modified radical mastectomy (MRM); safety; outcomes; local-regional recurrence (LRR); distant metastasis (DM); overall survival (OS);
D O I
10.3978/j.issn.2227-684X.2013.06.01
中图分类号
R61 [外科手术学];
学科分类号
摘要
Large multicenter clinical trials have demonstrated the safety of breast conserving surgery and radiation (BCT) compared to modified radical mastectomy (MRM). At 20 years follow-up, the European Organization of Research and Treatment of Cancer ( EORTC) 10801 trial reports the outcomes of distant metastasis (DM) and overall survival (OS) for stage 1 and 2 breast cancers treated from 1980-1986. Even though BCT had a higher 10 years local-regional recurrence (LRR) at 20% compared to MRM (12%), no significant difference was identified in long term OS (44% in the BCT group and 39% in the MRM group) or time to DM. Factors associated with increased LRR were dependent on biologic characteristics including larger tumor size, lymph node metastasis, and receptor subtype. BCT should be offered in appropriate patients when complete resection can be achieved. Continued research evaluating the heterogeneity of breast cancer subtypes will help further guide local-regional therapy for continued improvement in LRR, DM, and OS.
引用
收藏
页码:120 / 123
页数:4
相关论文
共 9 条
[1]   Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].
Fisher, B ;
Anderson, S ;
Bryant, J ;
Margolese, RG ;
Deutsch, M ;
Fisher, ER ;
Jeong, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1233-1241
[2]   Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy [J].
Houssami, Nehmat ;
Macaskill, Petra ;
Marinovich, M. Luke ;
Dixon, J. Michael ;
Irwig, Les ;
Brennan, Meagan E. ;
Solin, Lawrence J. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) :3219-3232
[3]   Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial [J].
Litiere, Saskia ;
Werutsky, Gustavo ;
Fentiman, Ian S. ;
Rutgers, Emiel ;
Christiaens, Marie-Rose ;
Van Limbergen, Erik ;
Baaijens, Margreet H. A. ;
Bogaerts, Jan ;
Bartelink, Harry .
LANCET ONCOLOGY, 2012, 13 (04) :412-419
[4]  
Mittendorf EA, ANN SURG IN PRESS
[5]   Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy [J].
Nguyen, Paul L. ;
Taghian, Alphonse G. ;
Katz, Matthew S. ;
Niemierko, Andrzej ;
Raad, Rita F. Abi ;
Boon, Whitney L. ;
Bellon, Jennifer R. ;
Wong, Julia S. ;
Smith, Barbara L. ;
Harris, Jay R. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (14) :2373-2378
[6]   Breast-Conserving Surgery and Radiotherapy in Early-Stage Breast Cancer: The Importance of Local Control [J].
Recht, Abram ;
Solin, Lawrence J. .
SEMINARS IN RADIATION ONCOLOGY, 2011, 21 (01) :3-9
[7]   Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study [J].
Solin, Lawrence J. ;
Gray, Robert ;
Goldstein, Lori J. ;
Recht, Abram ;
Baehner, Frederick L. ;
Shak, Steven ;
Badve, Sunil ;
Perez, Edith A. ;
Shulman, Lawrence N. ;
Martino, Silvana ;
Davidson, Nancy E. ;
Sledge, George W., Jr. ;
Sparano, Joseph A. .
BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (02) :683-692
[8]  
van Dongen J A, 1992, J Natl Cancer Inst Monogr, P15
[9]   Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial [J].
van Dongen, JA ;
Voogd, AC ;
Fentiman, IS ;
Legrand, C ;
Sylvester, RJ ;
Tong, D ;
van der Schueren, E ;
Helle, PA ;
van Zijl, K ;
Bartelink, H .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (14) :1143-1150